Term | Code | Class | Title |
---|---|---|---|
2020 S2 | BPHM2142 | 2A | Pharmacy in Body Systems Series: Gastrointestinal System, Drug Kinetics and Toxicities |
2020 S2 | MMPH6172 | 2C | Advances in Vascular Biology and Therapeutics |
2023 S1 | PHAR3366 | 1A | Clinical Pharmacology |
2023 S1 | PHAR4612 | 1A | Clinical Pharmacology |
2021 S1 | PHAR3366 | 1A | Clinical Pharmacology |
2021 S1 | PHAR4612 | 1A | Clinical Pharmacology |
2024 S2 | MMPH6172 | 2A | Advances in Vascular Biology and Therapeutics |
2024 S2 | PHAR6203 | 2A | Vascular biology and therapeutics |
2022 S2 | BPHM3146 | 2A | Pharmacy in Body Systems Series: Microbiology and Infectious Diseases |
2023 S2 | MMPH6172 | 2C | Advances in Vascular Biology and Therapeutics |
2022 S2 | BPHM2143 | 2A | Pharmacy in Body Systems Series: Cardiovascular and Renal |
2021 S2 | MMPH6172 | 2A | Advances in Vascular Biology and Therapeutics |
2021 S2 | PHAR6203 | 2A | Vascular biology and therapeutics |
2022 S2 | BPHM2142 | 2A | Pharmacy in Body Systems Series: Gastrointestinal System, Drug Kinetics and Toxicities |
2023 S2 | BPHM2143 | 2A | Pharmacy in Body Systems Series: Cardiovascular and Renal |
2023 S2 | BPHM3146 | 2A | Pharmacy in Body Systems Series: Microbiology and Infectious Diseases |
2018 S2 | MMPH6128 | 2C | Therapeutic Strategies for the Management of Cardiac and Respiratory Diseases |
2023 S2 | NURS7507 | 2A | Microbiology and Pharmacology for Nursing Practice |
2019 S2 | MMPH6128 | 2C | Therapeutic Strategies for the Management of Cardiac and Respiratory Diseases |
2021 S2 | NURS7507 | 2A | Microbiology and Pharmacology for Nursing Practice |
2020 S1 | BPHM2141 | 1A | Pharmacy in Body System Series - Respiratory System |
2020 S1 | BPHM3144 | 1A | Pharmacy in Body Systems Series: Endocrinology |
2019 S1 | BPHM3144 | 1A | Pharmacology and Clinical Pharmacy IV |
2021 S1 | BPHM2141 | 1A | Pharmacy in Body System Series - Respiratory System |
2021 S1 | BPHM3145 | 1A | Pharmacy in Body System Series: Central Nervous, Musculoskeletal and Connective Tissue Disorders |
2023 S2 | MMPH6172 | 2A | Advances in Vascular Biology and Therapeutics |
2023 S2 | PHAR6203 | 2A | Vascular biology and therapeutics |
2019 S1 | MMPH6172 | 1A | Advances in Vascular Biology and Therapeutics |
2019 S1 | MMPH6172 | 1C | Advances in Vascular Biology and Therapeutics |
2019 S1 | PHAR3334 | 1A | Clinical Pharmacology for Nurses |
2019 S1 | PHAR4612 | 1A | Clinical Pharmacology |
2019 S1 | PHAR6203 | 1A | Vascular biology and therapeutics |
2019 S2 | BPHM2142 | 2A | Pharmacy in Body Systems Series: Gastrointestinal System, Drug Kinetics and Toxicities |
2019 S2 | MMPH6128 | 2A | Therapeutic Strategies for the Management of Cardiac and Respiratory Diseases |
2019 S2 | PHAR6202 | 2A | Evidence based practice |
2022 S2 | MMPH6172 | 2C | Advances in Vascular Biology and Therapeutics |
2022 S2 | NURS7507 | 2A | Microbiology and Pharmacology for Nursing Practice |
2019 S2 | BPHM3146 | 2A | Advanced Pharmacology |
2018 S1 | PHAR4612 | 1A | Clinical Pharmacology |
2018 S2 | PHAR6202 | 2A | Drugs for the treatment of heart and lung diseases |
2020 S1 | PHAR3334 | 1A | Clinical Pharmacology for Nurses |
2020 S1 | PHAR4612 | 1A | Clinical Pharmacology |
2018 S1 | MMPH6172 | 1A | Advances in Vascular Biology and Therapeutics |
2018 S1 | PHAR3334 | 1A | Clinical Pharmacology for Nurses |
2018 S1 | PHAR6200 | FA | Current Development in Pharmacology and Pharmaceutics |
2018 S2 | BBMS3014 | 2A | Advanced Pharmacology |
2018 S2 | BPHM2142 | 2A | Pharmacology and Clinical Pharmacy II |
2018 S1 | BPHM3144 | 1A | Pharmacology and Clinical Pharmacy IV |
2018 S1 | PHAR6203 | 1A | Vascular biology and therapeutics |
2018 S2 | MMPH6128 | 2A | Therapeutic Strategies for the Management of Cardiac and Respiratory Diseases |
2018 S2 | PHAR6200 | FA | Current Development in Pharmacology and Pharmaceutics |
2023 S1 | BPHM2141 | 1A | Pharmacy in Body System Series - Respiratory System |
2023 S1 | BPHM3145 | 1A | Pharmacy in Body System Series: Central Nervous, Musculoskeletal and Connective Tissue Disorders |
2018 S1 | MMPH6172 | 1C | Advances in Vascular Biology and Therapeutics |
2021 S2 | MMPH6172 | 2C | Advances in Vascular Biology and Therapeutics |
2020 S2 | MMPH6172 | 2A | Advances in Vascular Biology and Therapeutics |
2020 S2 | PHAR6203 | 2A | Vascular biology and therapeutics |
2018 S2 | BPHM3146 | 2A | Advanced Pharmacology |
2020 S2 | BPHM2143 | 2A | Pharmacy in Body Systems Series: Cardiovascular and Renal |
2020 S2 | BPHM3146 | 2A | Pharmacy in Body Systems Series: Microbiology and Infectious Diseases |
2021 S2 | BPHM2143 | 2A | Pharmacy in Body Systems Series: Cardiovascular and Renal |
2021 S2 | BPHM3146 | 2A | Pharmacy in Body Systems Series: Microbiology and Infectious Diseases |
2022 S1 | PHAR3366 | 1A | Clinical Pharmacology |
2022 S1 | PHAR4612 | 1A | Clinical Pharmacology |
2022 S2 | MMPH6172 | 2A | Advances in Vascular Biology and Therapeutics |
2022 S2 | PHAR6203 | 2A | Vascular biology and therapeutics |
2022 S1 | BPHM2141 | 1A | Pharmacy in Body System Series - Respiratory System |
2022 S1 | BPHM3145 | 1A | Pharmacy in Body System Series: Central Nervous, Musculoskeletal and Connective Tissue Disorders |
2024 S1 | PHAR3366 | 1A | Clinical Pharmacology |
2024 S1 | PHAR4612 | 1A | Clinical Pharmacology |
Status | Thesis Title | Field of Study | Student |
---|---|---|---|
Development and optimization of KL4 peptide for pulmonary delivery of RNA | Drug Delivery, Pharmaceutics | 2017 Phd Qiu Yingshan | |
Mitochondrial transfer from induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial and smooth muscle cells attenuates oxidative stress-induced injury | Respiratory Medicine | 2012 Others Li Xiang | |
Therapeutic Arginine Depletion in Small Cell Lung Cancer: Preclinical Activity, Mechanisms and Resistance | Respiratory Medicine / Lung Cancer | 2014 Phd Xu Shi | |
Inhalable dry powders for pulmonary drug delivery | Pharmaceutics | 2012 Phd Chen Shuangning | |
Effects of Chinese green tea on cigarette smoke-induced oxidative stress, inflammation and proteases/anti-proteases in rat lung in vivo | Respiratory Medicine; Pharmacology | 2007 Phd Chan Ka Ho | |
Effects of intermittent hypoxia and hyperlipidemia-In vivo and in vitro studies on pathogenetic mechanisms linking obstructive sleep apnea to cardiovascular disease | Respiratory Medicine | 2007 Phd Han Qian | |
Therapeutic role of arsenic trioxide in small cell lung cancer: in vitro and in vivo models | Respiratory, Medicine, Oncology | 2010 Phd Zheng Chunyan | |
Development of Inhaled siRNA Formulation for Pulmonary Delivery | Pharmacy | 2013 Phd Chow Yee Tak | |
Challenges to Arterial Endothelial Function | Vascular Biology | 2008 Phd Chan Kiu Yan Calvin | |
Effects of Flavonoids on Cigarette Smoke and/or Lipopolysaccharide Induced Inflammation and Oxidative Stress in Human Bronchial Epithelial Cells and Rat Lung | Pharmacology | 2013 Phd Zhang Peng | |
Effects of human mesenchymal stem cells on cigarette smoke-induced lung damage | Respiratory Medicine | 2010 MPhil Li Xiang | |
The involvement of serotoninergic system in cigarette smoke-induced oxidative stress and inflammation – relevant to chronic obstructive pulmonary disease | Respiratory Medicine | 2008 Phd Lau Kwok Wai | |
The Role of Monoamine Oxidase (MAO) and Translocator Protein (TSPO) on Mechanisms Linking Cigarette Smoke to Airway Injury – In Vitro and In Vivo | Pharmacology | 2013 Phd Cui Yuting | |
The role of autophagy on targeted therapy in lung adenocarcinoma: in vitro and in vivo models | Respiratory Medicine, Oncology | 2010 Phd Li Yuanyuan | |
Tumour Growth Suppressive Effect of Arsenic Trioxide in Squamous Cell Lung Carcinoma | Lung Cancer | 2013 MPhil Leung Lee Leanne | |
The role of intermittent hypoxia on adipogenesis – in vivo and in vitro studies on pathogenic mechanisms linking obstructive sleep apnea to metabolic disorders | Respiratory | 2012 Phd Wang Yan | |
In vivo and in vitro studies on pathogenic mechanisms linking cigarette smoking to cardiovascular disease – what are the effects of human mesenchymal stem cells? | Respiratory Medicine | 2011 Phd Liang Yingmin | |
The role and mechanisms of interleukin-9 in facilitating anticancer effect of immunce checkpoint blockade in lung cancer animal model | Respiratory Medicine | 2018 Phd Feng Yuqian | |
The role of orosomucoid 1-like Protein 3 (ORMDL3) in cigarette smoke-induced airway injury | Airway Diseases | 2017 Phd Chen Rui |
Start Date | End Date | Committee | Category | Body |
---|---|---|---|---|
2010-07-01 | 2012-12-31 | Faculty of Medicine, Board of the | The teachers who are members of the Faculty and who are full-time employees of the University | |
2013-01-01 | 2018-06-30 | Faculty of Medicine, Board of the | The teachers who are members of the Faculty and who are full-time employees of the University |